184 related articles for article (PubMed ID: 11667981)
21. Immunohistochemical markers of cancerogenesis in the lung.
Pankiewicz W; Minarowski L; Niklińska W; Naumnik W; Nikliński J; Chyczewski L
Folia Histochem Cytobiol; 2007; 45(2):65-74. PubMed ID: 17597018
[TBL] [Abstract][Full Text] [Related]
22. Lung adenocarcinoma associated with atypical adenomatous hyperplasia. A clinicopathological study with special reference to smoking and cancer multiplicity.
Kitagawa H; Goto A; Niki T; Hironaka M; Nakajima J; Fukayama M
Pathol Int; 2003 Dec; 53(12):823-7. PubMed ID: 14629747
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
Lantuéjoul S; Salameire D; Salon C; Brambilla E
Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
[TBL] [Abstract][Full Text] [Related]
24. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
[TBL] [Abstract][Full Text] [Related]
25. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
Takigawa N; Ida M; Segawa Y; Nakata M; Mandai K; Kishino D; Fujiwara K; Saeki H; Takashima S; Eguchi K
Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
[TBL] [Abstract][Full Text] [Related]
26. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
[TBL] [Abstract][Full Text] [Related]
27. Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
Zhang C; Montironi R; MacLennan GT; Lopez-Beltran A; Li Y; Tan PH; Wang M; Zhang S; Iczkowski KA; Cheng L
Prostate; 2011 Dec; 71(16):1746-51. PubMed ID: 21480308
[TBL] [Abstract][Full Text] [Related]
28. Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.
Mori M; Chiba R; Takahashi T
Cancer; 1993 Oct; 72(8):2331-40. PubMed ID: 8402446
[TBL] [Abstract][Full Text] [Related]
29. LKB1 protein expression in the evolution of glandular neoplasia of the lung.
Ghaffar H; Sahin F; Sanchez-Cepedes M; Su GH; Zahurak M; Sidransky D; Westra WH
Clin Cancer Res; 2003 Aug; 9(8):2998-3003. PubMed ID: 12912948
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms.
Yokose T; Ito Y; Ochiai A
Lung Cancer; 2000 Aug; 29(2):125-30. PubMed ID: 10963842
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Dicer in precursor lesions of lung adenocarcinoma.
Chiosea S; Jelezcova E; Chandran U; Luo J; Mantha G; Sobol RW; Dacic S
Cancer Res; 2007 Mar; 67(5):2345-50. PubMed ID: 17332367
[TBL] [Abstract][Full Text] [Related]
32. Monoclonality of atypical adenomatous hyperplasia of the lung.
Niho S; Yokose T; Suzuki K; Kodama T; Nishiwaki Y; Mukai K
Am J Pathol; 1999 Jan; 154(1):249-54. PubMed ID: 9916939
[TBL] [Abstract][Full Text] [Related]
33. Expressions of ATF6, XBP1, and GRP78 in normal tissue, atypical adenomatous hyperplasia, and adenocarcinoma of the lung.
Ogata S; Kameda K; Kono T; Ozeki Y; Hashimoto H; Tominaga S; Nakanishi K
Hum Pathol; 2019 Jan; 83():22-28. PubMed ID: 30121368
[TBL] [Abstract][Full Text] [Related]
34. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry.
Shen J; Behrens C; Wistuba II; Feng L; Lee JJ; Hong WK; Lotan R
Cancer Res; 2006 Dec; 66(23):11194-206. PubMed ID: 17145864
[TBL] [Abstract][Full Text] [Related]
36. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.
Takamochi K; Ogura T; Suzuki K; Kawasaki H; Kurashima Y; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Esumi H
Am J Pathol; 2001 Nov; 159(5):1941-8. PubMed ID: 11696455
[TBL] [Abstract][Full Text] [Related]
38. Precursor lesions of adenocarcinoma lung--two case reports.
Jain D; Joshi K; Jindal SK
Indian J Pathol Microbiol; 2005 Jul; 48(3):399-402. PubMed ID: 16761769
[TBL] [Abstract][Full Text] [Related]
39. Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.
Sivakumar S; San Lucas FA; Jakubek YA; McDowell TL; Lang W; Kallsen N; Peyton S; Davies GE; Fukuoka J; Yatabe Y; Zhang J; Futreal PA; Fowler J; Fujimoto J; Ehli EA; Hawk ET; Wistuba II; Kadara H; Scheet P
EBioMedicine; 2019 Apr; 42():296-303. PubMed ID: 30905849
[TBL] [Abstract][Full Text] [Related]
40. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
